| Quantitation of carbon‐11‐labeled raclopride in rat striatum using positron emission tomography SP Hume, R Myers, PM Bloomfield, J Opacka‐Juffry, JE Cremer, RG Ahier, ... Synapse 12 (1), 47-54, 1992 | 243 | 1992 |
| Distribution and quantification of immunoreactive orexin A in rat tissues S Taheri, M Mahmoodi, J Opacka-Juffry, MA Ghatei, SR Bloom FEBS letters 457 (1), 157-161, 1999 | 199 | 1999 |
| Experience of stress in childhood negatively correlates with plasma oxytocin concentration in adult men J Opacka-Juffry, C Mohiyeddini Stress 15 (1), 1-10, 2012 | 165 | 2012 |
| Long-term effects of early life deprivation on brain glia in Fischer rats M Leventopoulos, D Rüedi-Bettschen, I Knuesel, J Feldon, CR Pryce, ... Brain research 1142, 119-126, 2007 | 148 | 2007 |
| Effect of L‐dopa and 6‐hydroxydopamine lesioning on [11C]raclopride binding in rat striatum, quantified using PET SP Hume, J Opacka‐Juffry, R Myers, RG Ahier, S Ashworth, DJ Brooks, ... Synapse 21 (1), 45-53, 1995 | 108 | 1995 |
| Long‐term protection of the rat nigrostriatal dopaminergic system by glial cell line‐derived neurotrophic factor against 6‐hydroxydopamine in vivo Blunt European Journal of Neuroscience 10 (1), 57-63, 1998 | 107 | 1998 |
| Effect of 5‐HT on binding of [11C] WAY 100635 to 5‐HT1A receptors in rat brain, assessed using in vivo microdialysis and PET after fenfluramine S Hume, E Hirani, J Opacka‐Juffry, R Myers, C Townsend, V Pike, ... Synapse 41 (2), 150-159, 2001 | 97 | 2001 |
| Early deprivation leads to long-term reductions in motivation for reward and 5-HT1A binding and both effects are reversed by fluoxetine M Leventopoulos, H Russig, J Feldon, CR Pryce, J Opacka-Juffry Neuropharmacology 56 (3), 692-701, 2009 | 92 | 2009 |
| PRE-CLINICAL DEVELOPMENT OF A RADIOLIGAND FOR STUDIES OF CENTRAL 5-HT1A RECEPTORS IN VIVO-(11C) WAY-100635 VW Pike, JA McCarron, SP Hume, S Ashworth, J Opacka-Juffry, S Osman, ... Medicinal Chemistry Research 5 (2), 208-227, 1995 | 88 | 1995 |
| GDNF protects against 6-OHDA nigrostriatal lesion: in vivo study with microdialysis and PET J Opacka-Juffry, S Ashworth, SP Hume, D Martin, DJ Brooks, SB Blunt Neuroreport 7 (1), 348-352, 1995 | 83 | 1995 |
| Evaluation of [O-methyl-3H] WAY-100635 as an in vivo radioligand for 5-HT1A receptors in rat brain SP Hume, S Ashworth, J Opacka-Juffry, RG Ahier, AA Lammertsma, ... European journal of pharmacology 271 (2-3), 515-523, 1994 | 82 | 1994 |
| Coexistence of gonadotrophin‐releasing hormone and Galanin: Immunohisto‐chemical and functional studies CW Coen, C Montagnese, J Opacka‐Juffry Journal of neuroendocrinology 2 (2), 107-111, 1990 | 81 | 1990 |
| Growth/differentiation factor 5 protects nigrostriatal dopaminergic neurones in a rat model of Parkinson's disease AM Sullivan, J Opacka-Juffry, G Hötten, J Pohl, SB Blunt Neuroscience letters 233 (2-3), 73-76, 1997 | 79 | 1997 |
| Nomifensine-induced increase in extracellular striatal dopamine is enhanced by isoflurane anaesthesia J Opacka-Juffry, RG Ahier, JE Cremer Synapse 7 (2), 169-171, 1991 | 78 | 1991 |
| Psychometric and neurobiological assessment of resilience in a non-clinical sample of adults N Petros, J Opacka-Juffry, JH Huber Psychoneuroendocrinology 38 (10), 2099-2108, 2013 | 76 | 2013 |
| Evaluation of [4‐O‐methyl‐11C]KW‐6002 as a potential PET ligand for mapping central adenosine A2A receptors in rats E Hirani, J Gillies, A Karasawa, J Shimada, H Kase, J Opacka‐Juffry, ... Synapse 42 (3), 164-176, 2001 | 62 | 2001 |
| Regulation of rat pituitary cocaine-and amphetamine-regulated transcript (CART) by CRH and glucocorticoids SA Stanley, KG Murphy, GA Bewick, WM Kong, J Opacka-Juffry, ... American Journal of Physiology-Endocrinology and Metabolism 287 (3), E583-E590, 2004 | 61 | 2004 |
| Chronic social stress induces peripheral and central immune activation, blunted mesolimbic dopamine function, and reduced reward-directed behaviour in mice G Bergamini, J Mechtersheimer, D Azzinnari, H Sigrist, M Buerge, ... Neurobiology of stress 8, 42-56, 2018 | 60 | 2018 |
| L‐Dihydroxyphenylalanine and its decarboxylase: New ideas on their neuroregulatory roles J Opacka‐Juffry, DJ Brooks Movement disorders: official journal of the Movement Disorder Society 10 (3 …, 1995 | 59 | 1995 |
| Spicing up pharmacology: a review of synthetic cannabinoids from structure to adverse events C Davidson, J Opacka-Juffry, A Arevalo-Martin, D Garcia-Ovejero, ... Advances in Pharmacology 80, 135-168, 2017 | 56 | 2017 |
